Evidence map›Paper›PMID 33179437›Full record

ArticleHLA2021

Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patients.

Yuk-Lin Yung, Chi-Keung Cheng, Hoi-Yun Chan, Jenny T Xia, Kin-Mang Lau, Raymond S M Wong, Alan K L Wu, Raymond W Chu, Alice C C Wong, Eudora Y D Chow and 4 more

Abstract read
In one paragraph

Article in HLA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Narrative Review Explaining the Role ofInfectious disease reports · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. The molecular mechanisms of CD8Frontiers in immunology · 2024
    Review
  9. The role of HLA genotypes in understanding the pathogenesis of severe COVID-19.The Egyptian journal of medical human genetics · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2022
    Article
  14. Article
  15. Article
  16. Host polymorphisms and COVID-19 infection.Advances in clinical chemistry · 2022
    Article
  17. Review
  18. Article
  19. Human genetic basis of coronavirus disease 2019.Signal transduction and targeted therapy · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yuk-Lin YungBlood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0002-9175-2915
Chi-Keung ChengBlood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Hoi-Yun ChanBlood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Jenny T XiaBlood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Kin-Mang LauBlood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Raymond S M WongDepartment of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Alan K L WuDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Raymond W ChuDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Alice C C WongDepartment of Pathology, United Christian Hospital, Hong Kong, China.
Eudora Y D ChowDepartment of Pathology, United Christian Hospital, Hong Kong, China.
Sze-Fai YipDepartment of Medicine, Tuen Mun Hospital, Hong Kong, China.
Jennifer N S LeungHong Kong Red Cross Blood Transfusion Service, Hong Kong, China.
Cheuk-Kwong LeeHong Kong Red Cross Blood Transfusion Service, Hong Kong, China.
Margaret H L NgBlood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

Funding

Research Grants Council, University Grants Committee CUHK M14108719
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by SARS-CoV-2. Since its first report in December 2019, COVID-19 has evolved into a global pandemic causing massive healthcare and socioeconomic challenges. HLA system is critical in mediating anti-viral immunity and recent studies have suggested preferential involvement of HLA-B in COVID-19 susceptibility. Here, by investigating the HLA-B genotypes in 190 unrelated Chinese patients with confirmed COVID-19, we identified a significant positive association between the B22 serotype and SARS-CoV-2 infection (p = 0.002, Bonferroni-corrected p = 0.032). Notably, the B22 serotype has been consistently linked to susceptibility to other viral infections. These data not only shed new insights into SARS-CoV-2 pathogenesis and vaccine development but also guide better infection prevention/control.

Indexed as

SARS-CoV-2AdolescentAdultAgedAged, 80 and overAsian PeopleCohort StudiesCOVID-19FemaleGenetic Predisposition to DiseaseHistocompatibility TestingHLA-B AntigensHong KongHumansImmunogenetic PhenomenaMaleHLA-B22 antigenHLA-B AntigensChinesecoronavirusCOVID-19HLASARS-CoV-2

Identifiers

PMID33179437
PMCPMC7898481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.